SlideShare a Scribd company logo
1 of 26
Michaelis Menten kinetic characteristics
Syed Umar Farooq
M pharm ( Ph.D)
Asst Professor
Care College of Pharmacy
contents
• Introduction
• Michaelis Menten characteristics'
• Assumptions and limitation
• Derivation
• Applications
• References
Definition
• The saturable concentration when the velocity of the
reaction is equal to half of the maximum velocity or 0.5 V
max
Nonlinear pharmacokinetics
• In some cases the rate process of drug depends on
carrier or enzyme that are substrate specific ,have
definite capacities and susceptible to saturation at
high concentration
• In such cases first order transforms in to mixture
of first order and zero order rate process and
pharmacokinetic parameters change with dose
• Pharmacokinetics of such drugs are said to be
dose-dependent, or mixed-order ,nonlinear and
capacity limited kinetics
Test to detect non linear
pharmacokinetics
• Determination of steady state plasma
concentration at different doses
• If steady state plasma concentration is directly
proportional to dose then linearity in kinetics exist.
• Determination of some of the important
pharmacokinetics parameter such as fractional bio
available, elimination half life or total systemic
clearance at different doses of drug any change in
these parameters indicate non linearity
Causes of non-linearity
• Occurs in Absorption
• When absorption involves carrier mediate
transport system eg. Absorption of
riboflavin, ascorbic acid
• When absorption is solubility or dissolution
rate limited e.g griseofulvin
• When pre systemic gut wall or hepatic
metabolism attains saturation
In drug distribution
• Non linearity in drug distribution of drugs
administered at high doses may be due to
• Saturation of binding sites on plasma
proteins e.g naproxen
• Saturation of tissue binding sites
• E,g thiopental and fentanyl
In metabolism
• Capacity limited metabolism due to enzyme and co factor
saturation
• E.g phenytoin alcohol
• Enzyme induction
• E.g carbamazepine
• In drug excretion
• Active tubular secretion e.g penciline g
• After saturation of carrier system a decrease in renal
claerence occur
• Active tubular re absorption e.g water soluble vitamins
Change in concentrations over time
for enzyme E, substrate S, complex
ES and product P
…
•-dc/dt=VmC/Km +C
• Where –dc/dt = rate of decline of drug
concentration at the time t,
• Vm = theoretical maximum rate of the
process.
• Km = michaelis menten constant.
characteristics
Three situation can be considered depending
up on values of Km and C
• When Km= C
• -dc/dt = Vmax/2
• i.e rate of process is equal to one half its
maximum rate
When Km = C
A plot of Michaelis Mentens
equation
When Km>>C
• Here Km + C = Km and equation reduces
to
• The above equation is identical to one that
describes to first order elimination of a drug
• i.e drug concentration in the body is below
Km
• PHENYTOIN and ALCOHOL are
exceptions
When Km << C
• Under this condition Km + C = C
• And equation will become
• the above equation is identical to
that of zero order process
• i.e. rate process occurs a constant rate Vmax
and is independent of drug concentration
• E.g metabolism of ethanol
Assumptions and limitations
• The first step in the derivation applies the
law of mass action, which is reliant on
free diffusion. However, in the environment
of a living cell where there is a high
concentration of protein, the cytoplasm
often behaves more like a gel than a liquid,
limiting molecular movements and altering
reaction rates
Equilibrium approximation
• In their original analysis, Michaelis and Menten assumed
that the substrate is in instantaneous chemical
equilibrium with the complex, and thus kf[E][S]
= kr[ES]. Combining this relationship with the enzyme
conservation law, the concentration of complex is
Contd…
• where Kd = kr / kf is the dissociation
constant for the enzyme-substrate complex.
Hence the velocity v of the reaction – the
rate at which P is formed – is
• where Vmax = kcat[E]0 is the maximum
reaction velocity.
Derivation
• Applying the law of mass action, which
states that the rate of a reaction is
proportional to the product of the
concentrations of the reactants, gives a
system of four non-linear ordinary
differential equations that define the rate of
change of reactants with time t
In this mechanism, the enzyme E is
a catalyst, which only facilitates the
reaction, so its total concentration, free
plus combined, [E] + [ES] = [E]0 is a
constant. This conservation law can also
be obtained by adding the second and
third equations above
Applications
Enzyme Km (M) kcat (1/s) kcat / Km (1/M.s)
Chymotrypsin 1.5 × 10-2 0.14 9.3
Pepsin 3.0 × 10-4 0.50 1.7 × 103
Tyrosyl-tRNA
synthetase
9.0 × 10-4 7.6 8.4 × 103
Ribonuclease 7.9 × 10-3 7.9 × 102 1.0 × 105
Carbonic
anhydrase
2.6 × 10-2 4.0 × 105 1.5 × 107
Fumarase 5.0 × 10-6 8.0 × 102 1.6 × 108
…
• The constant kcat / Km is a measure of
how efficiently an enzyme converts a
substrate into product. It has a
theoretical upper limit of 108 –
1010 /M.s; enzymes working close to
this, such as fumarase, are termed
superficies
Michaelis-Menten kinetics have also been applied to a variety
of spheres outside of biochemical reactions
• alveolar clearance of dusts
• the richness of species pools
• clearance of blood alcohol
• the photosynthesis-irradiance relationship
and bacterial phage infection
References
• Milo Gibaldi, pharmacokinetics second
edition, page no 271-278
• http://www.ncbi.nlm.nih.gov/books/NBK22
430/figure/A1052/?report=objectohttp://en.
• wikipedia.org/wiki/File:Michaelis-
Menten_saturation_curve_of_an_enzyme_r
eaction_LARGE.svgnly
Thank u………..

More Related Content

What's hot

Measurement of bioavailability
Measurement of bioavailabilityMeasurement of bioavailability
Measurement of bioavailabilityshikha singh
 
Methods of Assessing Bioavailability
Methods of Assessing BioavailabilityMethods of Assessing Bioavailability
Methods of Assessing BioavailabilityDibrugarh University
 
Two compartment model
Two compartment modelTwo compartment model
Two compartment modelRooma Khalid
 
Non linear Pharmacokinetics
Non linear PharmacokineticsNon linear Pharmacokinetics
Non linear PharmacokineticsAreej Abu Hanieh
 
P'kinetic parameters
P'kinetic parametersP'kinetic parameters
P'kinetic parametersAnil Joshi
 
one compartment model ppt
one compartment model pptone compartment model ppt
one compartment model pptSheetal Jha
 
Absorption of drugs from non per os extravascular administration
Absorption of drugs from non per os extravascular administrationAbsorption of drugs from non per os extravascular administration
Absorption of drugs from non per os extravascular administrationSuvarta Maru
 
Michaelis-menten kinetics
Michaelis-menten kineticsMichaelis-menten kinetics
Michaelis-menten kineticsMunawar Ali
 
WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)
WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)
WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)DR. METI.BHARATH KUMAR
 
Pharmacokinetics / Biopharmaceutics - Multi compartment IV bolus
Pharmacokinetics / Biopharmaceutics - Multi compartment IV bolusPharmacokinetics / Biopharmaceutics - Multi compartment IV bolus
Pharmacokinetics / Biopharmaceutics - Multi compartment IV bolusAreej Abu Hanieh
 
Drug interaction at plasma and tissue binding site
Drug interaction at plasma and tissue binding siteDrug interaction at plasma and tissue binding site
Drug interaction at plasma and tissue binding siteArabinda Changmai
 
Methods of enhancing Dissolution and bioavailability of poorly soluble drugs
Methods of enhancing Dissolution and bioavailability of poorly soluble drugsMethods of enhancing Dissolution and bioavailability of poorly soluble drugs
Methods of enhancing Dissolution and bioavailability of poorly soluble drugsRam Kanth
 

What's hot (20)

Pharmacokinetic models
Pharmacokinetic  modelsPharmacokinetic  models
Pharmacokinetic models
 
Measurement of bioavailability
Measurement of bioavailabilityMeasurement of bioavailability
Measurement of bioavailability
 
Methods of Assessing Bioavailability
Methods of Assessing BioavailabilityMethods of Assessing Bioavailability
Methods of Assessing Bioavailability
 
Nonlinear Pharmacokinetics
Nonlinear PharmacokineticsNonlinear Pharmacokinetics
Nonlinear Pharmacokinetics
 
Two compartment model
Two compartment modelTwo compartment model
Two compartment model
 
Non linear Pharmacokinetics
Non linear PharmacokineticsNon linear Pharmacokinetics
Non linear Pharmacokinetics
 
P'kinetic parameters
P'kinetic parametersP'kinetic parameters
P'kinetic parameters
 
one compartment model ppt
one compartment model pptone compartment model ppt
one compartment model ppt
 
Non linear pharmacokinetics
Non linear pharmacokineticsNon linear pharmacokinetics
Non linear pharmacokinetics
 
Non compartment model
Non compartment modelNon compartment model
Non compartment model
 
Pharmacokinetic models
Pharmacokinetic modelsPharmacokinetic models
Pharmacokinetic models
 
Absorption of drugs from non per os extravascular administration
Absorption of drugs from non per os extravascular administrationAbsorption of drugs from non per os extravascular administration
Absorption of drugs from non per os extravascular administration
 
MECHANISMS OF DRUG ABSORPTION
MECHANISMS OF DRUG  ABSORPTIONMECHANISMS OF DRUG  ABSORPTION
MECHANISMS OF DRUG ABSORPTION
 
Michaelis-menten kinetics
Michaelis-menten kineticsMichaelis-menten kinetics
Michaelis-menten kinetics
 
WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)
WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)
WAGNER NELSON METHOD (Contact me: dr.m.bharathkumar@gmail.com)
 
Bioavailability Studies
Bioavailability StudiesBioavailability Studies
Bioavailability Studies
 
Pharmacokinetics / Biopharmaceutics - Multi compartment IV bolus
Pharmacokinetics / Biopharmaceutics - Multi compartment IV bolusPharmacokinetics / Biopharmaceutics - Multi compartment IV bolus
Pharmacokinetics / Biopharmaceutics - Multi compartment IV bolus
 
In-Vivo In-Vitro Correlation
In-Vivo In-Vitro CorrelationIn-Vivo In-Vitro Correlation
In-Vivo In-Vitro Correlation
 
Drug interaction at plasma and tissue binding site
Drug interaction at plasma and tissue binding siteDrug interaction at plasma and tissue binding site
Drug interaction at plasma and tissue binding site
 
Methods of enhancing Dissolution and bioavailability of poorly soluble drugs
Methods of enhancing Dissolution and bioavailability of poorly soluble drugsMethods of enhancing Dissolution and bioavailability of poorly soluble drugs
Methods of enhancing Dissolution and bioavailability of poorly soluble drugs
 

Similar to Michaelis menten kinetics Nonlinear Pharmacokinetics

Non linear kinetics
Non linear kineticsNon linear kinetics
Non linear kineticsSuvarta Maru
 
NONLINEAR PHARMACOKINETICS_ppt.pdf
NONLINEAR PHARMACOKINETICS_ppt.pdfNONLINEAR PHARMACOKINETICS_ppt.pdf
NONLINEAR PHARMACOKINETICS_ppt.pdfKirti Goel
 
Non linear pharmacokinetics
Non linear pharmacokineticsNon linear pharmacokinetics
Non linear pharmacokineticsShashi Yadav
 
Nonlinear pharmacokinetic
Nonlinear pharmacokineticNonlinear pharmacokinetic
Nonlinear pharmacokineticbuner12345
 
kineticsofstabilityanstabilitytesting-200327002128.pdf
kineticsofstabilityanstabilitytesting-200327002128.pdfkineticsofstabilityanstabilitytesting-200327002128.pdf
kineticsofstabilityanstabilitytesting-200327002128.pdffarsiya
 
Kinetics of stability and stability testing
Kinetics of stability and stability testingKinetics of stability and stability testing
Kinetics of stability and stability testingAnkit Malik
 
Concept of nonlinear pharmacokinetic
Concept of nonlinear pharmacokineticConcept of nonlinear pharmacokinetic
Concept of nonlinear pharmacokinetickavita bahmani
 
ENZYME INHIBITION & FACTORS AFFECTING THE VELOCITY OF ENZYME ACTION
ENZYME INHIBITION & FACTORS AFFECTING THE VELOCITY OF ENZYME ACTIONENZYME INHIBITION & FACTORS AFFECTING THE VELOCITY OF ENZYME ACTION
ENZYME INHIBITION & FACTORS AFFECTING THE VELOCITY OF ENZYME ACTIONYESANNA
 
Pharacokinetics power point for pharmacy
Pharacokinetics power point  for pharmacyPharacokinetics power point  for pharmacy
Pharacokinetics power point for pharmacyemebetnigatu1
 
BPharma-6Sem-Biopharmaceutics & Pharmacokinetics.pdf
BPharma-6Sem-Biopharmaceutics & Pharmacokinetics.pdfBPharma-6Sem-Biopharmaceutics & Pharmacokinetics.pdf
BPharma-6Sem-Biopharmaceutics & Pharmacokinetics.pdfKaamDhenu
 
enzyyyyyyyymessss.pdf
enzyyyyyyyymessss.pdfenzyyyyyyyymessss.pdf
enzyyyyyyyymessss.pdfAnujJha71
 
Latest enzyme edit
Latest enzyme editLatest enzyme edit
Latest enzyme editUmi Biee
 
Basic concepts of pharmacokinetics
Basic concepts of pharmacokineticsBasic concepts of pharmacokinetics
Basic concepts of pharmacokineticsAnand Addagalla
 
Basic concepts of pharmacokinetics
Basic concepts of pharmacokineticsBasic concepts of pharmacokinetics
Basic concepts of pharmacokineticsAnand Addagalla
 
Basic Pharmacokinetics & Compartments Modelling.pdf
Basic Pharmacokinetics & Compartments Modelling.pdfBasic Pharmacokinetics & Compartments Modelling.pdf
Basic Pharmacokinetics & Compartments Modelling.pdfAshwin Saxena
 
Basic pharmacokinetics and compartment modelling
Basic pharmacokinetics  and compartment modellingBasic pharmacokinetics  and compartment modelling
Basic pharmacokinetics and compartment modellingPriyankaDabirBharadk
 
Enzyme notes biochemistry Satyanarayan.pdf
Enzyme notes biochemistry Satyanarayan.pdfEnzyme notes biochemistry Satyanarayan.pdf
Enzyme notes biochemistry Satyanarayan.pdfitsmesuveksha
 
basicpharmacokineticsandcompatmentmodelling-171223090651.ppt
basicpharmacokineticsandcompatmentmodelling-171223090651.pptbasicpharmacokineticsandcompatmentmodelling-171223090651.ppt
basicpharmacokineticsandcompatmentmodelling-171223090651.pptTohfatulJinan1
 

Similar to Michaelis menten kinetics Nonlinear Pharmacokinetics (20)

Non linear kinetics
Non linear kineticsNon linear kinetics
Non linear kinetics
 
NONLINEAR PHARMACOKINETICS_ppt.pdf
NONLINEAR PHARMACOKINETICS_ppt.pdfNONLINEAR PHARMACOKINETICS_ppt.pdf
NONLINEAR PHARMACOKINETICS_ppt.pdf
 
Non linear pharmacokinetics
Non linear pharmacokineticsNon linear pharmacokinetics
Non linear pharmacokinetics
 
Nonlinear pharmacokinetic
Nonlinear pharmacokineticNonlinear pharmacokinetic
Nonlinear pharmacokinetic
 
kineticsofstabilityanstabilitytesting-200327002128.pdf
kineticsofstabilityanstabilitytesting-200327002128.pdfkineticsofstabilityanstabilitytesting-200327002128.pdf
kineticsofstabilityanstabilitytesting-200327002128.pdf
 
Kinetics of stability and stability testing
Kinetics of stability and stability testingKinetics of stability and stability testing
Kinetics of stability and stability testing
 
Concept of nonlinear pharmacokinetic
Concept of nonlinear pharmacokineticConcept of nonlinear pharmacokinetic
Concept of nonlinear pharmacokinetic
 
ENZYME INHIBITION & FACTORS AFFECTING THE VELOCITY OF ENZYME ACTION
ENZYME INHIBITION & FACTORS AFFECTING THE VELOCITY OF ENZYME ACTIONENZYME INHIBITION & FACTORS AFFECTING THE VELOCITY OF ENZYME ACTION
ENZYME INHIBITION & FACTORS AFFECTING THE VELOCITY OF ENZYME ACTION
 
Pharacokinetics power point for pharmacy
Pharacokinetics power point  for pharmacyPharacokinetics power point  for pharmacy
Pharacokinetics power point for pharmacy
 
BPharma-6Sem-Biopharmaceutics & Pharmacokinetics.pdf
BPharma-6Sem-Biopharmaceutics & Pharmacokinetics.pdfBPharma-6Sem-Biopharmaceutics & Pharmacokinetics.pdf
BPharma-6Sem-Biopharmaceutics & Pharmacokinetics.pdf
 
Saturation kinetics
Saturation kineticsSaturation kinetics
Saturation kinetics
 
enzyyyyyyyymessss.pdf
enzyyyyyyyymessss.pdfenzyyyyyyyymessss.pdf
enzyyyyyyyymessss.pdf
 
Latest enzyme edit
Latest enzyme editLatest enzyme edit
Latest enzyme edit
 
Basic concepts of pharmacokinetics
Basic concepts of pharmacokineticsBasic concepts of pharmacokinetics
Basic concepts of pharmacokinetics
 
Basic concepts of pharmacokinetics
Basic concepts of pharmacokineticsBasic concepts of pharmacokinetics
Basic concepts of pharmacokinetics
 
Basic Pharmacokinetics & Compartments Modelling.pdf
Basic Pharmacokinetics & Compartments Modelling.pdfBasic Pharmacokinetics & Compartments Modelling.pdf
Basic Pharmacokinetics & Compartments Modelling.pdf
 
Basic pharmacokinetics and compartment modelling
Basic pharmacokinetics  and compartment modellingBasic pharmacokinetics  and compartment modelling
Basic pharmacokinetics and compartment modelling
 
Enzyme notes biochemistry Satyanarayan.pdf
Enzyme notes biochemistry Satyanarayan.pdfEnzyme notes biochemistry Satyanarayan.pdf
Enzyme notes biochemistry Satyanarayan.pdf
 
Enzyme kinetics
Enzyme kineticsEnzyme kinetics
Enzyme kinetics
 
basicpharmacokineticsandcompatmentmodelling-171223090651.ppt
basicpharmacokineticsandcompatmentmodelling-171223090651.pptbasicpharmacokineticsandcompatmentmodelling-171223090651.ppt
basicpharmacokineticsandcompatmentmodelling-171223090651.ppt
 

Recently uploaded

Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?Patrick Diehl
 
BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.
BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.
BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.PraveenaKalaiselvan1
 
Solution chemistry, Moral and Normal solutions
Solution chemistry, Moral and Normal solutionsSolution chemistry, Moral and Normal solutions
Solution chemistry, Moral and Normal solutionsHajira Mahmood
 
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝soniya singh
 
Speech, hearing, noise, intelligibility.pptx
Speech, hearing, noise, intelligibility.pptxSpeech, hearing, noise, intelligibility.pptx
Speech, hearing, noise, intelligibility.pptxpriyankatabhane
 
Transposable elements in prokaryotes.ppt
Transposable elements in prokaryotes.pptTransposable elements in prokaryotes.ppt
Transposable elements in prokaryotes.pptArshadWarsi13
 
The dark energy paradox leads to a new structure of spacetime.pptx
The dark energy paradox leads to a new structure of spacetime.pptxThe dark energy paradox leads to a new structure of spacetime.pptx
The dark energy paradox leads to a new structure of spacetime.pptxEran Akiva Sinbar
 
GenBio2 - Lesson 1 - Introduction to Genetics.pptx
GenBio2 - Lesson 1 - Introduction to Genetics.pptxGenBio2 - Lesson 1 - Introduction to Genetics.pptx
GenBio2 - Lesson 1 - Introduction to Genetics.pptxBerniceCayabyab1
 
Pests of safflower_Binomics_Identification_Dr.UPR.pdf
Pests of safflower_Binomics_Identification_Dr.UPR.pdfPests of safflower_Binomics_Identification_Dr.UPR.pdf
Pests of safflower_Binomics_Identification_Dr.UPR.pdfPirithiRaju
 
Pests of soyabean_Binomics_IdentificationDr.UPR.pdf
Pests of soyabean_Binomics_IdentificationDr.UPR.pdfPests of soyabean_Binomics_IdentificationDr.UPR.pdf
Pests of soyabean_Binomics_IdentificationDr.UPR.pdfPirithiRaju
 
Environmental Biotechnology Topic:- Microbial Biosensor
Environmental Biotechnology Topic:- Microbial BiosensorEnvironmental Biotechnology Topic:- Microbial Biosensor
Environmental Biotechnology Topic:- Microbial Biosensorsonawaneprad
 
Analytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptxAnalytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptxSwapnil Therkar
 
OECD bibliometric indicators: Selected highlights, April 2024
OECD bibliometric indicators: Selected highlights, April 2024OECD bibliometric indicators: Selected highlights, April 2024
OECD bibliometric indicators: Selected highlights, April 2024innovationoecd
 
TOPIC 8 Temperature and Heat.pdf physics
TOPIC 8 Temperature and Heat.pdf physicsTOPIC 8 Temperature and Heat.pdf physics
TOPIC 8 Temperature and Heat.pdf physicsssuserddc89b
 
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.aasikanpl
 
Neurodevelopmental disorders according to the dsm 5 tr
Neurodevelopmental disorders according to the dsm 5 trNeurodevelopmental disorders according to the dsm 5 tr
Neurodevelopmental disorders according to the dsm 5 trssuser06f238
 
Harmful and Useful Microorganisms Presentation
Harmful and Useful Microorganisms PresentationHarmful and Useful Microorganisms Presentation
Harmful and Useful Microorganisms Presentationtahreemzahra82
 
BUMI DAN ANTARIKSA PROJEK IPAS SMK KELAS X.pdf
BUMI DAN ANTARIKSA PROJEK IPAS SMK KELAS X.pdfBUMI DAN ANTARIKSA PROJEK IPAS SMK KELAS X.pdf
BUMI DAN ANTARIKSA PROJEK IPAS SMK KELAS X.pdfWildaNurAmalia2
 

Recently uploaded (20)

Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?Is RISC-V ready for HPC workload? Maybe?
Is RISC-V ready for HPC workload? Maybe?
 
BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.
BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.
BIOETHICS IN RECOMBINANT DNA TECHNOLOGY.
 
Solution chemistry, Moral and Normal solutions
Solution chemistry, Moral and Normal solutionsSolution chemistry, Moral and Normal solutions
Solution chemistry, Moral and Normal solutions
 
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝
Call Girls in Munirka Delhi 💯Call Us 🔝8264348440🔝
 
Speech, hearing, noise, intelligibility.pptx
Speech, hearing, noise, intelligibility.pptxSpeech, hearing, noise, intelligibility.pptx
Speech, hearing, noise, intelligibility.pptx
 
Transposable elements in prokaryotes.ppt
Transposable elements in prokaryotes.pptTransposable elements in prokaryotes.ppt
Transposable elements in prokaryotes.ppt
 
The dark energy paradox leads to a new structure of spacetime.pptx
The dark energy paradox leads to a new structure of spacetime.pptxThe dark energy paradox leads to a new structure of spacetime.pptx
The dark energy paradox leads to a new structure of spacetime.pptx
 
GenBio2 - Lesson 1 - Introduction to Genetics.pptx
GenBio2 - Lesson 1 - Introduction to Genetics.pptxGenBio2 - Lesson 1 - Introduction to Genetics.pptx
GenBio2 - Lesson 1 - Introduction to Genetics.pptx
 
Pests of safflower_Binomics_Identification_Dr.UPR.pdf
Pests of safflower_Binomics_Identification_Dr.UPR.pdfPests of safflower_Binomics_Identification_Dr.UPR.pdf
Pests of safflower_Binomics_Identification_Dr.UPR.pdf
 
Pests of soyabean_Binomics_IdentificationDr.UPR.pdf
Pests of soyabean_Binomics_IdentificationDr.UPR.pdfPests of soyabean_Binomics_IdentificationDr.UPR.pdf
Pests of soyabean_Binomics_IdentificationDr.UPR.pdf
 
Environmental Biotechnology Topic:- Microbial Biosensor
Environmental Biotechnology Topic:- Microbial BiosensorEnvironmental Biotechnology Topic:- Microbial Biosensor
Environmental Biotechnology Topic:- Microbial Biosensor
 
Analytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptxAnalytical Profile of Coleus Forskohlii | Forskolin .pptx
Analytical Profile of Coleus Forskohlii | Forskolin .pptx
 
OECD bibliometric indicators: Selected highlights, April 2024
OECD bibliometric indicators: Selected highlights, April 2024OECD bibliometric indicators: Selected highlights, April 2024
OECD bibliometric indicators: Selected highlights, April 2024
 
Hot Sexy call girls in Moti Nagar,🔝 9953056974 🔝 escort Service
Hot Sexy call girls in  Moti Nagar,🔝 9953056974 🔝 escort ServiceHot Sexy call girls in  Moti Nagar,🔝 9953056974 🔝 escort Service
Hot Sexy call girls in Moti Nagar,🔝 9953056974 🔝 escort Service
 
Volatile Oils Pharmacognosy And Phytochemistry -I
Volatile Oils Pharmacognosy And Phytochemistry -IVolatile Oils Pharmacognosy And Phytochemistry -I
Volatile Oils Pharmacognosy And Phytochemistry -I
 
TOPIC 8 Temperature and Heat.pdf physics
TOPIC 8 Temperature and Heat.pdf physicsTOPIC 8 Temperature and Heat.pdf physics
TOPIC 8 Temperature and Heat.pdf physics
 
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
Call Girls in Mayapuri Delhi 💯Call Us 🔝9953322196🔝 💯Escort.
 
Neurodevelopmental disorders according to the dsm 5 tr
Neurodevelopmental disorders according to the dsm 5 trNeurodevelopmental disorders according to the dsm 5 tr
Neurodevelopmental disorders according to the dsm 5 tr
 
Harmful and Useful Microorganisms Presentation
Harmful and Useful Microorganisms PresentationHarmful and Useful Microorganisms Presentation
Harmful and Useful Microorganisms Presentation
 
BUMI DAN ANTARIKSA PROJEK IPAS SMK KELAS X.pdf
BUMI DAN ANTARIKSA PROJEK IPAS SMK KELAS X.pdfBUMI DAN ANTARIKSA PROJEK IPAS SMK KELAS X.pdf
BUMI DAN ANTARIKSA PROJEK IPAS SMK KELAS X.pdf
 

Michaelis menten kinetics Nonlinear Pharmacokinetics

  • 1. Michaelis Menten kinetic characteristics Syed Umar Farooq M pharm ( Ph.D) Asst Professor Care College of Pharmacy
  • 2. contents • Introduction • Michaelis Menten characteristics' • Assumptions and limitation • Derivation • Applications • References
  • 3. Definition • The saturable concentration when the velocity of the reaction is equal to half of the maximum velocity or 0.5 V max
  • 4. Nonlinear pharmacokinetics • In some cases the rate process of drug depends on carrier or enzyme that are substrate specific ,have definite capacities and susceptible to saturation at high concentration • In such cases first order transforms in to mixture of first order and zero order rate process and pharmacokinetic parameters change with dose • Pharmacokinetics of such drugs are said to be dose-dependent, or mixed-order ,nonlinear and capacity limited kinetics
  • 5. Test to detect non linear pharmacokinetics • Determination of steady state plasma concentration at different doses • If steady state plasma concentration is directly proportional to dose then linearity in kinetics exist. • Determination of some of the important pharmacokinetics parameter such as fractional bio available, elimination half life or total systemic clearance at different doses of drug any change in these parameters indicate non linearity
  • 6. Causes of non-linearity • Occurs in Absorption • When absorption involves carrier mediate transport system eg. Absorption of riboflavin, ascorbic acid • When absorption is solubility or dissolution rate limited e.g griseofulvin • When pre systemic gut wall or hepatic metabolism attains saturation
  • 7. In drug distribution • Non linearity in drug distribution of drugs administered at high doses may be due to • Saturation of binding sites on plasma proteins e.g naproxen • Saturation of tissue binding sites • E,g thiopental and fentanyl
  • 8. In metabolism • Capacity limited metabolism due to enzyme and co factor saturation • E.g phenytoin alcohol • Enzyme induction • E.g carbamazepine • In drug excretion • Active tubular secretion e.g penciline g • After saturation of carrier system a decrease in renal claerence occur • Active tubular re absorption e.g water soluble vitamins
  • 9. Change in concentrations over time for enzyme E, substrate S, complex ES and product P
  • 10. … •-dc/dt=VmC/Km +C • Where –dc/dt = rate of decline of drug concentration at the time t, • Vm = theoretical maximum rate of the process. • Km = michaelis menten constant.
  • 11.
  • 12. characteristics Three situation can be considered depending up on values of Km and C • When Km= C • -dc/dt = Vmax/2 • i.e rate of process is equal to one half its maximum rate
  • 13. When Km = C A plot of Michaelis Mentens equation
  • 14. When Km>>C • Here Km + C = Km and equation reduces to • The above equation is identical to one that describes to first order elimination of a drug • i.e drug concentration in the body is below Km • PHENYTOIN and ALCOHOL are exceptions
  • 15. When Km << C • Under this condition Km + C = C • And equation will become • the above equation is identical to that of zero order process • i.e. rate process occurs a constant rate Vmax and is independent of drug concentration • E.g metabolism of ethanol
  • 16.
  • 17. Assumptions and limitations • The first step in the derivation applies the law of mass action, which is reliant on free diffusion. However, in the environment of a living cell where there is a high concentration of protein, the cytoplasm often behaves more like a gel than a liquid, limiting molecular movements and altering reaction rates
  • 18. Equilibrium approximation • In their original analysis, Michaelis and Menten assumed that the substrate is in instantaneous chemical equilibrium with the complex, and thus kf[E][S] = kr[ES]. Combining this relationship with the enzyme conservation law, the concentration of complex is
  • 19. Contd… • where Kd = kr / kf is the dissociation constant for the enzyme-substrate complex. Hence the velocity v of the reaction – the rate at which P is formed – is • where Vmax = kcat[E]0 is the maximum reaction velocity.
  • 20. Derivation • Applying the law of mass action, which states that the rate of a reaction is proportional to the product of the concentrations of the reactants, gives a system of four non-linear ordinary differential equations that define the rate of change of reactants with time t
  • 21. In this mechanism, the enzyme E is a catalyst, which only facilitates the reaction, so its total concentration, free plus combined, [E] + [ES] = [E]0 is a constant. This conservation law can also be obtained by adding the second and third equations above
  • 22. Applications Enzyme Km (M) kcat (1/s) kcat / Km (1/M.s) Chymotrypsin 1.5 × 10-2 0.14 9.3 Pepsin 3.0 × 10-4 0.50 1.7 × 103 Tyrosyl-tRNA synthetase 9.0 × 10-4 7.6 8.4 × 103 Ribonuclease 7.9 × 10-3 7.9 × 102 1.0 × 105 Carbonic anhydrase 2.6 × 10-2 4.0 × 105 1.5 × 107 Fumarase 5.0 × 10-6 8.0 × 102 1.6 × 108
  • 23. … • The constant kcat / Km is a measure of how efficiently an enzyme converts a substrate into product. It has a theoretical upper limit of 108 – 1010 /M.s; enzymes working close to this, such as fumarase, are termed superficies
  • 24. Michaelis-Menten kinetics have also been applied to a variety of spheres outside of biochemical reactions • alveolar clearance of dusts • the richness of species pools • clearance of blood alcohol • the photosynthesis-irradiance relationship and bacterial phage infection
  • 25. References • Milo Gibaldi, pharmacokinetics second edition, page no 271-278 • http://www.ncbi.nlm.nih.gov/books/NBK22 430/figure/A1052/?report=objectohttp://en. • wikipedia.org/wiki/File:Michaelis- Menten_saturation_curve_of_an_enzyme_r eaction_LARGE.svgnly